Cyclophosphamide-induced disruption of umami taste functions and taste epithelium

Neuroscience

Volumn 192, Issue , 2011, Pages 732-745

  Mukherjee, N ^a   Delay, E R ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Animal psychophysics; Chemotherapy; Cytotoxicity; Taste acuity; Taste cell renewal; Umami

Indexed keywords

CYCLOPHOSPHAMIDE; GLUTAMATE SODIUM; INOSINE PHOSPHATE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CIRCUMVALLATE TASTE BUD; CONTROLLED STUDY; FUNGIFORM PAPILLA; MALE; MOUSE; NONHUMAN; PERCEPTIVE DISCRIMINATION; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; SALIVATION; SENSITIVITY ANALYSIS; SENSORY SYSTEM; TASTE ACUITY; TASTE BUD; TASTE DISCRIMINATION; TASTE DISORDER; UMAMI TASTE DISORDER; VON EBNER GLAND;

ANIMALS; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; MALE; MICE; MICE, INBRED C57BL; TASTE; TASTE BUDS;

EID: 80052270705     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.07.006     Document Type: Article

References (114)

1. Ader R., Cohen N. Behaviorally conditioned immunosuppression. Psychosom Med 1975, 37:333-340.
2. Ahles T.A., Saykin A.J. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer 2002, 3(Suppl 3):S84-S90.
3. Aronovitch M., Meakins J.F., Groszman M. Use of cyclophosphamide in advanced malignancies. Can Med Assoc J 1960, 83:997-1002.
4. Asano-Miyoshi M., Hamamichi R., Emori Y. Cytokeratin 14 is expressed in immature cells in rat taste buds. J Mol Histol 2008, 39:193-199.
5. Bachmanov A.A., Beauchamp G.K. Genetics of intake of umami-tasting solutions by mice. Sens Neur 2001, 3:205-212.
6. Bachmanov A.A., Tordoff M.G., Beauchamp G.K. Intake of umami-tasting solutions by mice: a genetic analysis. J Nutr 2000, 130:935S-941S.
7. Bagley C.M., Bostick F.W., DeVita V.T. Clinical pharmacology of cyclophosphamide. Cancer Res 1973, 33:226-233.
8. Bartoshuk L.M. Chemosensory alterations and cancer therapies. NCI Monogr 1990, 179-184.
9. Beidler L.M., Smallman R.L. Renewal of cells within taste buds. J Cell Biol 1965, 27:263-272.
10. Bellisle F., Dalix A.M., Chappuis F., Rossi F., Fiquet P., Gaudin V., Assoun M., Slama G. Monosodium glutamate affects meal-time food selection in diabetic patients. Appetite 1996, 26:267-276.
11. Bellisle F., Monneuse M.O., Chabert M., Larue-Achagiotis C., Lanteaume M.T., Louis-Sylvrestre J. Monosodium glutamate as a palatability enhancer in the European diet. Physiol Behav 1991, 49:869-873.
12. Bernhardson B.M., Tishelman C., Rutqvist L.E. Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage 2007, 34:403-412.
13. Bernhardson B.M., Tishelman C., Rutqvist L.E. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 2008, 16:275-283.
14. Bernhardson B.M., Tishelman C., Rutqvist L.E. Taste and Smell changes in patients receiving cancer chemotherapy: distress, impact on daily life, and self-care strategies. Cancer Nurs 2009, 32:45-54.
15. Bernstein I.L. Learned taste aversions in children receiving chemotherapy. Science 1978, 200:1302-1303.
16. Bernstein I.L. Learned food aversions in the progression of cancer and its treatment. Ann N Y Acad Sci 1985, 443:365-380.
17. Bernstein I.L., Goehler L.E., Fenner D.P. Learned aversions to proteins in rats on a dietary self-selection regimen. Behav Neurosci 1984, 98:1065-1072.
18. Bernstein I.L., Webster M.M. Learned taste aversions in humans. Physiol Behav 1980, 25:363-366.
19. Berteretche M.V., Dalix A.M., d'Ornano A.M., Bellisle F., Khayat D., Faurion A. Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer 2004, 12:571-576.
20. Bouton M. Learning and behaviour: a contemporary synthesis 2007, Sinauer Associates, Inc, Sunderland, MA.
21. Bovbjerg D.H., Redd W.H., Jacobsen P.B., Manne S.L., Taylor K.L., Surbone A., Crown J.P., Norton L., Gilewski T.A., Hudis C.A., et al. An experimental analysis of classically conditioned nausea during cancer chemotherapy. Psychosom Med 1992, 54:623-637.
22. Brock N. Oxazaphosphorine cytostatics: past-present-future. Seventh Cain Memorial Award lecture. Cancer Res 1989, 49:1-7.
23. Brosvic G.M., Slotnick B.M. Absolute and intensity-difference taste thresholds in the rat: evaluation of an automated multi-channel gustometer. Physiol Behav 1986, 38:711-717.
24. Carson J.A., Gormican A. Taste acuity and food attitudes of selected patients with cancer. J Am Diet Assoc 1977, 70:361-365.
25. Chaudhari N., Roper S.D. The cell biology of taste. J Cell Biol 2010, 190:285-296.
26. Chaudhari N., Yang H., Lamp C., Delay E., Cartford C., Than T., Roper S. The taste of monosodium glutamate: membrane receptors in taste buds. J Neurosci 1996, 16:3817-3826.
27. Cheng K.K. Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs 2007, 16:2114-2121.
28. Cheng K.K., Chang A.M. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs 2003, 26:476-484.
29. Cohen J.L., Jao J.Y. Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. J Pharmacol Exp Ther 1970, 174:206-210.
30. Colvin O.M. An overview of cyclophosphamide development and clinical applications. Curr Pharm Des 1999, 5:555-560.
31. Comeau T.B., Epstein J.B., Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer 2001, 9:575-580.
32. Cummings T.A., Delay R.J., Roper S.D. Ultrastructure of apical specializations of taste cells in the mudpuppy, Necturus maculosus. J Comp Neurol 1987, 261:604-615.
33. Cunningham D., Cummings J., Blackie R.B., McTaggart L., Banham S.W., Kaye S.B., Soukop M. The pharmacokinetics of high dose cyclophosphamide and high dose etoposide. Med Oncol Tumor Pharmacother 1988, 5:117-123.
34. Davis C.M., Riley A.L. Conditioned taste aversion learning: implications for animal models of drug abuse. Ann N Y Acad Sci 2010, 1187:247-275.
35. de Jonge M.E., Huitema A.D., Rodenhuis S., Beijnen J.H. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 2005, 44:1135-1164.
36. de Jonghe B.C., Horn C.C. Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat. Am J Physiol Regul Integr Comp Physiol 2008, 294(3):R756-R765.
37. Dekaney C.M., Gulati A.S., Garrison A.P., Helmrath M.A., Henning S.J. Regeneration of intestinal stem/progenitor cells following doxorubicin treatment in mice. Am J Phsyiol Gastrointest Liver Physiol 2009, 297:G461-G470.
38. Delay E.R., Eddy M.C., Eschle B.K. Behavioral studies of umami: tales told by mice and rats. Ann N Y Acad Sci 2009, 1170:41-45.
39. Delay E.R., Hernandez N.P., Bromley K., Margolskee R.F. Sucrose and monosodium glutamate taste thresholds and discrimination ability of T1R3 knockout mice. Chem Senses 2006, 31:351-357.
40. Delay E.R., Sewczak G.M., Stapleton J.R., Roper S.D. Glutamate taste: discrimination between the tastes of glutamate agonists and monosodium glutamate in rats. Chem Senses 2004, 29:291-299.
41. Delay R.J., Kinnamon J.C., Roper S.D. Ultrastructure of mouse vallate taste buds: II. Cell types and cell lineage. J Comp Neurol 1986, 253:242-252.
42. Dong Q., Barsky D., Colvin M.E., Melius C.F., Ludeman S.M., Moravek J.F., Colvin O.M., Bigner D.D., Modrich P., Friedman H.S. A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5'-d(GAC). Proc Natl Acad Sci U S A 1995, 92:12170-12174.
43. Eddy M.C., Eschle B.K., Barrows J., Hallock R.M., Finger T.E., Delay E.R. Double P2X2/P2X3 purinergic receptor knockout mice do not taste NaCl or the artificial sweetener SC45647. Chem Senses 2009, 34:789-797.
44. Epstein J.B., Phillips N., Parry J., Epstein M.S., Nevill T., Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002, 30:785-792.
45. Eschle B.K., Eddy M.C., Delay E.R. Antagonism of metabotropic glutamate receptor 4 receptors by (RS)-alpha-cyclopropyl-4-phosphonophenylglycine alters the taste of amino acids in rats. Neuroscience 2009, 163:1292-1301.
46. Eylam S., Spector A.C. Oral amiloride treatment decreases taste sensitivity to sodium salts in C57BL/6J and DBA/2J mice. Chem Sens 2003, 28:447-458.
47. Eylam S., Tracy T., Garcea M., Spector A.C. Amiloride is an ineffective conditioned stimulus in taste aversion learning in C57BL/6J and DBA/2J mice. Chem Senses 2003, 28:681-689.
48. Farbman A.I. Renewal of taste bud cells in rat circumvallate papillae. Cell Tissue Kinet 1980, 13:349-357.
49. Fernbach D.J., Sutow W.W., Thurman W.G., Vietti T.J. Preliminary report: clinical trials with cyclophosphamide in children with acute leukemia. Cancer Chemother Rep 1960, 8:102-105.
50. Fernbach D.J., Sutow W.W., Thurman W.G., Vietti T.J. Clinical trials with cyclophosphamide in the treatment of acute leukemia in children. Cancer Chemother Rep 1962, 16:173-176.
51. Finger T.E. Cell types and lineages in taste buds. Chem Senses 2005, 30(Suppl 1):i54-i55.
52. Foye L.V., Chapman C.G., Willett F.M., Adams W.S. Cyclophosphamide. A preliminary study of a new alkylating agent. Arch Intern Med 1960, 106:365-367.
53. Goodman L.S., Gilman A. The pharmacological basis of therapeutics 1975, Macmillan, New York, NY. 5th ed.
54. Gor P.P., Su H.I., Gray R.J., Gimotty P.A., Horn M., Aplenc R., Vaughan W.P., Tallman M.S., Rebbeck T.R., DeMichele A. Cyclophosphamide-metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study. Breast Cancer Res 2010, 12:R26.
55. Greene P.G., Seime R.J. Stimulus control of anticipatory nausea in cancer chemotherapy. J Behav Ther Exp Psychiatry 1987, 18:61-64.
56. Hall J.C., Staniland J.R., Giles G.R. Altered taste thresholds in gastro-intestinal cancer. Clin Oncol 1980, 6:137-142.
57. Heck G.L., Mierson S., DeSimone J.A. Salt taste transduction occurs through an amiloride-sensitive sodium transport pathway. Science 1984, 223:403-405.
58. Heyer B.R., Taylor-Burds C.C., Mitzelfelt J.D., Delay E.R. Monosodium glutamate and sweet taste: discrimination between the tastes of sweet stimuli and glutamate in rats. Chem Senses 2004, 29:721-729.
59. Heyer B.R., Taylor-Burds C.C., Tran L.H., Delay E.R. Monosodium glutamate and sweet taste: generalization of conditioned taste aversion between glutamate and sweet stimuli in rats. Chem Senses 2003, 28(7):631-641.
60. Hong J.H., Omur-Ozbek P., Stanek B.T., Dietrich A.M., Duncan S.E., Lee Y.W., Lesser G. Taste and odor abnormalities in cancer patients. J Support Oncol 2009, 7:58-65.
61. Host H., Nissen-Meyer R. A preliminary clinical study of cyclophosphamide. Cancer Chemother Rep 1960, 9:47-50.
62. Huguenin P.U., Taussky D., Moe K., Meister A., Baumert B., Lutolf U.M., Glanzmann C. Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: the importance of the target volume. Int J Radiat Oncol Biol Phys 1999, 45:47-52.
63. Hume W.J., Potten C.S. The ordered columnar structure of mouse filiform papillae. J Cell Sci 1976, 22:149-160.
64. Hutton J.L., Baracos V.E., Wismer W.V. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 2007, 33:156-165.
65. Iwasaki S., Yoshizawa H., Kawahara I. Study by scanning electron microscopy of the morphogenesis of three types of lingual papilla in the rat. Anat Rec 1997, 247:528-541.
66. Jansen C.E., Miaskowski C., Dodd M., Dowling G. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature. Oncol Nurs Forum 2005, 32:329-342.
67. Juma F.D., Koech D.K., Kasili E.G., Ogada T. Pharmacokinetics of cyclophosphamide in Kenyan African children with lymphoma. Br J Clin Pharmacol 1984, 18:106-107.
68. Juma F.D., Rogers H.J., Trounce J.R. The kinetics of salivary elimination of cyclophosphamide in man. Br J Clin Pharmacol 1979, 8:455-458.
69. Juma F.D., Rogers H.J., Trounce J.R. Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br J Clin Pharmacol 1979, 8:209-217.
70. Juma F.D., Rogers H.J., Trounce J.R. First pass hepatic metabolism of cyclophosphamide [proceedings]. Br J Clin Pharmacol 1979, 7:422P.
71. Juma F.D., Rogers H.J., Trounce J.R. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy. Br J Clin Pharmacol 1980, 10:327-335.
72. Kinnamon J.C. Organization and innervation of taste buds. Neurobiology of taste and smell 1987, 277-297. Wiley, New York. T.E. Finger, W.L. Silver (Eds.).
73. Kovacs E.T., Ohno S., Kinosita R. Studies on cyclophosphamide, antitumor alkylating compound. I. Effect on mouse leukemias. J Natl Cancer Inst 1960, 24:759-768.
74. Lambert J.V., Whitehouse W.G. Conditioned inhibition of cyclophosphamide-induced taste aversion. J Gen Psychol 2002, 129:68-75.
75. Lin A.L., Johnson D.A., Wu Y., Wong G., Ebersole J.L., Yeh C.K. Measuring short-term gamma-irradiation effects on mouse salivary gland function using a new saliva collection device. Arch Oral Biol 2001, 46:1085-1089.
76. Ludeman S.M. The chemistry of the metabolites of cyclophosphamide. Curr Pharm Des 1999, 5:627-643.
77. MacQueen G.M., Siegel S. Conditional immunomodulation following training with cyclophosphamide. Behav Neurosci 1989, 103:638-647.
78. Malet-Martino M., Gilard V., Martino R. The analysis of cyclophosphamide and its metabolites. Curr Pharm Des 1999, 5:561-586.
79. Matsuo R. Role of saliva in the maintenance of taste sensitivity. Crit Rev Oral Biol Med 2000, 11:216-229.
80. Matsuo R., Yamauchi Y., Morimoto T. Role of submandibular and sublingual saliva in maintenance of taste sensitivity recorded in the chorda tympani of rats. J Physiol 1997, 498(Pt 3):797-807.
81. Mattes R.D., Arnold C., Boraas M. Learned food aversions among cancer chemotherapy patients. Incidence, nature, and clinical implications. Cancer 1987, 60:2576-2580.
82. Mese H., Matsuo R. Salivary secretion, taste and hyposalivation. J Oral Rehabil 2007, 34:711-723.
83. Miura H., Kusakabe Y., Harada S. Cell lineage and differentiation in taste buds. Arch Histol Cytol 2006, 69:209-225.
84. Moore M.J. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 1991, 20:194-208.
85. Murata Y., Beauchamp G.K., Bachmanov A.A. Taste perception of monosodium glutamate and inosine monophosphate by 129P3/J and C57BL/6ByJ mice. Physiol Behav 2009, 98:481-488.
86. Halyard M.Y. Taste and smell alterations in cancer patients-real problems with few solutions. J Support Oncol 2009, 7:68-69.
87. Nakayama A., Miura H., Shindo Y., Kusakabe Y., Tomonari H., Harada S. Expression of the basal cell markers of taste buds in the anterior tongue and soft palate of the mouse embryo. J Comp Neurol 2008, 509:211-224.
88. Okubo T., Clark C., Hogan B.L. Cell lineage mapping of taste bud cells and keratinocytes in the mouse tongue and soft palate. Stem Cells 2009, 27:442-450.
89. Olin J.J. Cognitive function after systemic therapy for breast cancer. Oncology (Williston Park) 2001, 15:613-618. discussion:618, 621-614.
90. Parks J.D., Whitehead M.C. Scanning electron microscopy of denervated taste buds in hamster: morphology of fungiform taste pores. Anat Rec 1998, 251:230-239.
91. Petros W.P., Broadwater G., Berry D., Jones R.B., Vredenburgh J.J., Gilbert C.J., Gibbs J.P., Colvin O.M., Peters W.P. Association of high-dose cyclophosphamide, cisplatin, and carmustine pharmacokinetics with survival, toxicity, and dosing weight in patients with primary breast cancer. Clin Cancer Res 2002, 8:698-705.
92. Pinto N., Ludeman S.M., Dolan M.E. Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy. Pharmacogenomics 2009, 10:1897-1903.
93. Povirk L.F., Shuker D.E. DNA damage and mutagenesis induced by nitrogen mustards. Mutat Res 1994, 318:205-226.
94. Powers J.F., Sladek N.E. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats. Cancer Res 1983, 43:1101-1106.
95. Sanderson B.J., Shield A.J. Mutagenic damage to mammalian cells by therapeutic alkylating agents. Mutat Res 1996, 355:41-57.
96. Schiffman S.S., Sattely-Miller E.A., taylor E.L., Graham B.G., Landerman L.R., Zervakis J., Campagna L.K., Cohen H.J., Blackwell S., Garst J.L. Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. Nutr Health. Aging 2007, 11:439-454.
97. Schuler U., Waidelich P., Kolb H., Wagner T., Ehninger G. Pharmacokinetics and metabolism of cyclophosphamide administered after total body irradiation of bone marrow transplant recipients. Eur J Clin Pharmacol 1991, 40:521-523.
98. Shi H.B., Masuda M., Umezaki T., Kuratomi Y., Kumamoto Y., Yamamoto T., Komiyama S. Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx 2004, 31:401-406.
99. Shiboski C.H., Hodgson T.A., Ship J.A., Schiodt M. Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103(Suppl S66). e61-e19.
100. Spector A.C. Psychophysical Evaluation of taste function in nonhuman mammals. Handbook of olfaction and gestation 2003, 861-879. Marcel Dekker, New York, NY. 2nd ed. R.L. Doty (Ed.).
101. Stapleton J.R., Luellig M., Roper S.D., Delay E.R. Discrimination between the tastes of sucrose and monosodium glutamate in rats. Chem Senses 2002, 27:375-382.
102. Stapleton J.R., Roper S.D., Delay E.R. The taste of monosodium glutamate (MSG), l-aspartic acid, and N-methyl-d-aspartate (NMDA) in rats: are NMDA receptors involved in MSG taste?. Chem Senses 1999, 24:449-457.
103. Stone L.M., Tan S.S., Tam P.P., Finger T.E. Analysis of cell lineage relationships in taste buds. J Neurosci 2002, 22:4522-4529.
104. Trotti A., Bellm L.A., Epstein J.B., Frame D., Fuchs H.J., Gwede C.K., Komaroff E., Nalysnyk L., Zilberberg M.D. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003, 66:253-262.
105. Viale P.H. Update on the management of chemotherapy-induced nausea and vomiting. J Infus Nurs 2006, 29:283-292.
106. Wickham R.S., Rehwaldt M., Kefer C., Shott S., Abbas K., Glynn-Tucker E., Potter C., Blendowski C. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum 1999, 26:697-706.
107. Wifall T.C., Faes T.M., Taylor-Burds C.C., Mitzelfelt J.D., Delay E.R. An analysis of 5'-inosine and 5'-guanosine monophosphate taste in rats. Chem Senses 2007, 32:161-172.
108. Yamamoto T., Matsuo R., Fujimoto Y., Fukunaga I., Miyasaka A., Imoto T. Electrophysiological and behavioral studies on the taste of umami substances in the rat. Physiol Behav 1991, 49:919-925.
109. Yamashita H., Nakagawa K., Hosoi Y., Kurokawa A., Fukuda Y., Matsumoto I., Misaka T., Abe K. Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer. Oral Oncol 2009, 45:e19-e23.
110. Yamazaki M., Fujii S., Ochiai A. Reduction of type II taste cells correlates with taste dysfunction after X-ray irradiation in mice. J Oral Pathol Med 2010, 39:212-218.
111. Yasuo T., Kusuhara Y., Yasumatsu K., Ninomiya Y. Multiple receptor systems for glutamate detection in the taste organ. Biol Pharm Bull 2008, 31:1833-1837.
112. Yoshida R., Yasumatsu K., Shirosaki S., Jyotaki M., Horio N., Murata Y., Shigemura N., Nakashima K., Ninomiya Y. Multiple receptor systems for umami taste in mice. Ann N Y Acad Sci 2009, 1170:51-54.
113. Yule S.M., Price L., Cole M., Pearson A.D., Boddy A.V. Cyclophosphamide metabolism in children with Fanconi's anaemia. Bone Marrow Transplant 1999, 24:123-128.
114. Zhao G.Q., Zhang Y., Hoon M.A., Chandrashekar J., Erlenbach I., Ryba N.J., Zuker C.S. The receptors for mammalian sweet and umami taste. Cell 2003, 115:255-266.